| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Canada | 2 | |
| #4 | Israel | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Norway | 1 | |
| #7 | New Zealand | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Heterocyclic compounds | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Self Christopher R | 12 |
| #2 | Olson Gary L | 9 |
| #3 | Cook Charles M | 9 |
| #4 | Scudiero Dominic | 4 |
| #5 | Colasanti Andrew | 4 |
| #6 | Jobson Andy | 4 |
| #7 | Waugh David | 4 |
| #8 | Cardellina John | 4 |
| #9 | Zhang Guangtao | 4 |
| #10 | Shoemaker Robert | 4 |
| Publication | Filing date | Title |
|---|---|---|
| AU2008331789A1 | Inhibitors of antigen presentation by MHC Class II molecules and methods of use thereof | |
| AU2008267081A1 | Kinase inhibitors, compositions thereof, and methods of use therewith | |
| NZ542256A | Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof |